MedTrace Logo

Effects of Adaptive Servoventilation in Patients With Systolic Heart Failure and Sleep-Disordered Breathing

NCT01657188 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 550

Last updated 2019-09-04

No results posted yet for this study

Summary

Prospective, follow-up registry of heart failure patients with or without sleep-disordered breathing (SDB). To test the hypothesis that treatment of nocturnal central sleep apnea with Cheyne-Stokes respiration by adaptive servoventilation (ASV) improves symptoms, cardiac performance and event-free survival.

Conditions

  • Heart Failure, Congestive
  • Sleep Apnea Syndromes
  • Adaptive Servoventilation

Interventions

DEVICE

Cheyne-Stokes respiration by adaptive servoventilation

Sponsors & Collaborators

  • Ruhr University of Bochum

    lead OTHER

Principal Investigators

  • Olaf Oldenburg, M.D. · Heart and Diabetes Center North Rhine-Westphalia, Ruhr University Bochum

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2016-02-29
Completion
2017-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01657188 on ClinicalTrials.gov